Bruce Jackson

1.3k total citations
58 papers, 893 citations indexed

About

Bruce Jackson is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruce Jackson has authored 58 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruce Jackson's work include Renin-Angiotensin System Studies (16 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Heart Failure Treatment and Management (5 papers). Bruce Jackson is often cited by papers focused on Renin-Angiotensin System Studies (16 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Heart Failure Treatment and Management (5 papers). Bruce Jackson collaborates with scholars based in Australia, United States and Germany. Bruce Jackson's co-authors include Colin I. Johnston, David J. Berlowitz, Frederick A.O. Mendelsohn, Wen Kwang Lim, Rose Perich, Siew Yeen Chai, Bruno Fabris, George Jerums, Leon A. Bach and Terri J. Allen and has published in prestigious journals such as Diabetes, Endocrinology and The Journal of Urology.

In The Last Decade

Bruce Jackson

56 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Jackson Australia 18 477 204 167 112 103 58 893
Luc Poirier Canada 21 716 1.5× 149 0.7× 309 1.9× 46 0.4× 59 0.6× 71 1.2k
James F. Burris United States 16 314 0.7× 116 0.6× 138 0.8× 33 0.3× 54 0.5× 61 710
Harold S. Solomon United States 12 358 0.8× 380 1.9× 218 1.3× 336 3.0× 47 0.5× 18 1.4k
Scott L. Mader United States 22 424 0.9× 455 2.2× 135 0.8× 63 0.6× 129 1.3× 43 1.5k
Martin G. Myers Canada 19 539 1.1× 110 0.5× 130 0.8× 36 0.3× 40 0.4× 26 1.2k
M. L. Mashford Australia 16 173 0.4× 132 0.6× 152 0.9× 42 0.4× 25 0.2× 39 867
Rafael García‐Robles Spain 17 483 1.0× 114 0.6× 381 2.3× 47 0.4× 23 0.2× 43 1.1k
Yingxian Sun China 24 626 1.3× 196 1.0× 231 1.4× 86 0.8× 18 0.2× 84 1.4k
Mark S. Pecker United States 16 541 1.1× 179 0.9× 205 1.2× 216 1.9× 10 0.1× 24 1.1k
D. J. Sumner United Kingdom 19 265 0.6× 163 0.8× 83 0.5× 112 1.0× 11 0.1× 53 1.1k

Countries citing papers authored by Bruce Jackson

Since Specialization
Citations

This map shows the geographic impact of Bruce Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Jackson more than expected).

Fields of papers citing papers by Bruce Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Jackson. The network helps show where Bruce Jackson may publish in the future.

Co-authorship network of co-authors of Bruce Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Jackson. A scholar is included among the top collaborators of Bruce Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Jackson. Bruce Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanna, Mary, et al.. (2018). Validation of a risk stratification tool for a Hospital Outreach Medication Review (HOMR) program. Research in Social and Administrative Pharmacy. 15(9). 1133–1137. 6 indexed citations
2.
Barker, Anna, Peter Barlis, David J. Berlowitz, et al.. (2011). Pharmacist directed home medication reviews in patients with chronic heart failure: A randomised clinical trial. International Journal of Cardiology. 159(2). 139–143. 45 indexed citations
3.
Moore, Rosemary, David J. Berlowitz, Jeffrey J. Pretto, et al.. (2009). Acute effects of hyperoxia on resting pattern of ventilation and dyspnoea in COPD. Respirology. 14(4). 545–550. 8 indexed citations
4.
Morton, Natalie A. de, Jennifer L. Keating, David J. Berlowitz, Bruce Jackson, & Wen Kwang Lim. (2007). Additional exercise does not change hospital or patient outcomes in older medical patients: a controlled clinical trial. Australian Journal of Physiotherapy. 53(2). 105–111. 51 indexed citations
5.
6.
Lowe, Adrian J., et al.. (2003). Clustering effects of chronic obstructive pulmonary disease specific quality of life in hospitalized patients. Respirology. 8(3). 339–343. 1 indexed citations
7.
Jandeleit‐Dahm, Karin, Louise M. Burrell, Masayuki Kanazawa, et al.. (1998). Effects of Neutral Endopeptidase Inhibition in the Rat Remnant Kidney Model. Kidney & Blood Pressure Research. 21(6). 419–424. 4 indexed citations
8.
Black, M. Jane, Todd A. Briscoe, John F. Bertram, Bruce Jackson, & Colin I. Johnston. (1997). CARDIAC HYPERTROPHY IN DIABETIC SPONTANEOUSLY HYPERTENSIVE RATS: ROLE OF ANGIOTENSIN II?. Clinical and Experimental Pharmacology and Physiology. 24(6). 445–448. 6 indexed citations
9.
Perich, Rose, Bruce Jackson, & Colin I. Johnston. (1994). Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme. European Journal of Pharmacology Molecular Pharmacology. 266(3). 201–211. 21 indexed citations
10.
Morris, Brian J., et al.. (1994). GENOTYPIC INFLUENCE ON PLASMA DIPEPTIDYL CARBOXYPEPTIDASE‐1 ACTIVITY IN HYPERTENSIVES. Clinical and Experimental Pharmacology and Physiology. 21(4). 343–346. 11 indexed citations
11.
Jandeleit, Karin, Rose Perich, Bruce Jackson, & Colin I. Johnston. (1992). MESENTERIC RESISTANCE AND BRAIN MICROVASCULAR ANGIOTENSIN‐CONVERTING ENZYME IN THE SPONTANEOUSLY HYPERTENSIVE RAT. Clinical and Experimental Pharmacology and Physiology. 19(5). 348–352. 8 indexed citations
12.
Perich, Rose, Bruce Jackson, & Colin I. Johnston. (1992). VARIATION IN ANGIOTENSIN‐CONVERTING ENZYME (ACE) INHIBITOR AFFINITY AT TWO BINDING SITES ON RAT PULMONARY ACE: INFLUENCE ON BRADYKININ HYDROLYSIS. Clinical and Experimental Pharmacology and Physiology. 19(5). 353–357. 5 indexed citations
13.
Jandeleit, Karin, et al.. (1991). ANGIOTENSIN‐CONVERTING ENZYME IN MACRO‐AND MICROVESSELS OF THE RAT. Clinical and Experimental Pharmacology and Physiology. 18(5). 353–356. 7 indexed citations
14.
Mendelsohn, Frederick A.O., et al.. (1991). Acute and Chronic Effects of Perindopril on Tissue Angiotensin Converting Enzyme Activity. American Journal of Hypertension. 4(3_Pt_2). 220S–225S. 9 indexed citations
15.
Fabris, Bruno, et al.. (1990). Characterization of cardiac angiotensin converting enzyme (ACE) andin vivoinhibition following oral quinapril to rats. British Journal of Pharmacology. 100(3). 651–655. 30 indexed citations
16.
Fabris, Bruno, et al.. (1989). ANGIOTENSIN CONVERTING ENZYME IN THE RAT HEART: STUDIES OF ITS INHIBITION IN VITRO AND EX VIVO. Clinical and Experimental Pharmacology and Physiology. 16(4). 309–313. 33 indexed citations
17.
18.
Jackson, Bruce, et al.. (1988). Effects of Perindopril on Tissue Angiotensin-Converting Enzyme Activity Demonstrated by Quantitative in vitro Autoradiography. Journal of Cardiovascular Pharmacology. 12(6). 710–717. 22 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luc Poirier Breakdown of academic impact, for papers by James F. Burris Breakdown of academic impact, for papers by Harold S. Solomon Breakdown of academic impact, for papers by Scott L. Mader Breakdown of academic impact, for papers by Martin G. Myers Breakdown of academic impact, for papers by M. L. Mashford Breakdown of academic impact, for papers by Rafael García‐Robles Breakdown of academic impact, for papers by Yingxian Sun Breakdown of academic impact, for papers by Mark S. Pecker Breakdown of academic impact, for papers by D. J. Sumner
Rankless by CCL
2026